共 50 条
CCR 20th Anniversary Commentary: Simpson's Paradox and Neoadjuvant Trials
被引:4
|作者:
Carey, Lisa A.
[1
]
机构:
[1] Univ N Carolina, Chapel Hill, NC 27599 USA
关键词:
TUMOR-INFILTRATING LYMPHOCYTES;
NEGATIVE BREAST-CANCER;
PATHOLOGICAL COMPLETE RESPONSE;
SURVIVAL OUTCOMES;
PREDICTIVE-VALUE;
CHEMOTHERAPY;
CARBOPLATIN;
SUBTYPES;
THERAPY;
TRASTUZUMAB;
D O I:
10.1158/1078-0432.CCR-14-3124
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
The research article by Carey and colleagues, published in the April 15, 2007, issue of Clinical Cancer Research, described the relationship between response to neoadjuvant chemotherapy and outcome by tumor subtype. Today neoadjuvant clinical trials are often designed to provide correlative data to help identify predictive biomarkers or to focus on poor-risk patients identified by residual disease after neoadjuvant treatment. © 2015 American Association for Cancer Research.
引用
收藏
页码:4027 / 4029
页数:3
相关论文